COPD Drug Developments

We are pleased to share that Dr Pete Wilson, GP Partner and Site Principal Investigator has co-authored a piece on understanding cardiopulmonary risk in COPD and opportunities for new treatment modalities, alongside Yang Xu, Head of Medical Affairs Respiratory at AstraZeneca UK.

You can view the paper at the below link:

https://middlewoodpartnership.co.uk/epr-oped-dr-pete-wilson-yang-zu/